Insider Trading activities of Crinetics Pharmaceuticals, Inc. (CRNX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Crinetics Pharmaceuticals, Inc. (CRNX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Crinetics Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Crinetics Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is CRNX. The reporting company's CIK number is 1658247.
The total value of stock buying since 2005 is $15,122,576.
The total value of stock sales since 2005 is $25,589,235.
The total value of stock option exercises since 2005 is $25,785.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Crinetics Pharmaceuticals, Inc. (CRNX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2020-02 0 $0 26,920 $598,475 0 $0
2020-01 0 $0 26,920 $594,164 0 $0
2019-12 0 $0 3,500 $78,750 3,500 $6,685
2019-08 0 $0 0 $0 10,000 $19,100
2019-06 0 $0 250,000 $5,550,000 0 $0
2019-03 0 $0 571,839 $13,033,250 0 $0
2019-01 0 $0 262,153 $5,734,596 0 $0
2018-07 870,180 $15,122,576 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Crinetics Pharmaceuticals, Inc. insiders (CRNX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-02-10 Vivo Opportunity Fund, L.p. Sale 7,555 21.40 161,677
2020-02-07 Vivo Opportunity Fund, L.p. Sale 5,905 22.00 129,910
2020-02-04 Vivo Opportunity Fund, L.p. Sale 13,460 22.80 306,888
2020-01-31 Vivo Opportunity Fund, L.p. Sale 5,400 21.70 117,180
2020-01-30 Vivo Opportunity Fund, L.p. Sale 7,600 22.10 167,960
2020-01-29 Vivo Opportunity Fund, L.p. Sale 13,920 22.20 309,024
2019-12-16 Fust Matthew K (Director) Sale 3,500 22.50 78,750
2019-12-16 Fust Matthew K (Director) Option Ex 3,500 1.91 6,685
2019-08-05 Struthers Richard Scott (President & CEO) Option Ex 10,000 1.91 19,100
2019-06-21 Schwab Andrew J. (Other) Sale 250,000 22.20 5,550,000
2019-03-20 Vivo Opportunity Fund, L.p. Sale 417,000 22.25 9,278,250
2019-03-18 Schwab Andrew J. (10% Owner) Sale 154,839 24.25 3,755,000
2019-01-22 Schwab Andrew J. (10% Owner) Sale 262,153 21.88 5,734,596
2018-07-20 Vivo Opportunity Fund, L.p. Buy 353,180 17.93 6,333,576
2018-07-20 Schwab Andrew J. (10% Owner) Buy 115,000 17.00 1,955,000
2018-07-20 Krasner Alan Seth (Chief Medical Officer) Buy 2,000 17.00 34,000
2018-07-20 Edelman Joseph (10% Owner) Buy 400,000 17.00 6,800,000

Insider trading activities including stock purchases, stock sales, and option exercises of CRNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Crinetics Pharmaceuticals, Inc. (symbol CRNX, CIK number 1658247) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month